We are live on ! Find out more
BDTX icon

Black Diamond Therapeutics
BDTX

109 hedge funds and large institutions have $915M invested in Black Diamond Therapeutics in 2020 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 43 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

291% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 11

175% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 12

28% more capital invested

Capital invested by funds: $717M → $915M (+$198M)

24% more funds holding

Funds holding: 88 → 109 (+21)

13.2% more ownership

Funds ownership: 66.17% → 79.37% (+13%)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
109
Holders Change
+21
Holders Change %
+23.86%
% of All Funds
1.93%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
33
Increased
43
Reduced
11
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$19.9M
2
BlackRock
BlackRock
New York
+$18.9M
3
State Street
State Street
Massachusetts
+$17.9M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$10.8M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.67M

Top Sellers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
-$4.4M
2
IC
Ikarian Capital
Texas
-$2.14M
3
SG Americas Securities
SG Americas Securities
New York
-$1.3M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$817K
5
TC
Telemus Capital
Michigan
-$506K
Name Holding Trade Value Shares
Change 		Change in
Stake
Lord, Abbett & Co
26
Lord, Abbett & Co
New Jersey
$8.39M +$3.55M +108,067 +70%
Adage Capital Partners
27
Adage Capital Partners
Massachusetts
$7.47M +$2.89M +88,000 +61%
PCM
28
Peregrine Capital Management
Minnesota
$6.73M +$605K +18,411 +10%
Northern Trust
29
Northern Trust
Illinois
$6.54M -$56.6K -1,723 -0.8%
MWNA
30
Marshall Wace North America
New York
$5.8M +$5.95M +181,008 New
Millennium Management
31
Millennium Management
New York
$5.55M +$4.43M +134,886 +351%
TG
32
TCW Group
California
$5.33M +$5.46M +166,318 New
Two Sigma Investments
33
Two Sigma Investments
New York
$4.04M +$4.14M +126,140 New
LGM
34
Logos Global Management
California
$3.96M – – –
Morgan Stanley
35
Morgan Stanley
New York
$3.58M +$3.39M +103,150 +1,212%
Charles Schwab
36
Charles Schwab
California
$3.47M +$51.2K +1,558 +1%
Norges Bank
37
Norges Bank
Norway
$3.21M – – –
Goldman Sachs
38
Goldman Sachs
New York
$2.32M +$2.12M +64,384 +818%
ACH
39
ArrowMark Colorado Holdings
Colorado
$2.24M – – –
Bank of New York Mellon
40
Bank of New York Mellon
New York
$2.04M +$162K +4,934 +8%
N
41
Nuveen
North Carolina
$2.03M -$70.5K -2,145 -3%
Bank of America
42
Bank of America
North Carolina
$1.85M +$941K +28,634 +99%
Marshall Wace
43
Marshall Wace
United Kingdom
$1.38M +$1.42M +43,081 New
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$1.28M +$85.6K +2,607 +7%
Prudential Financial
45
Prudential Financial
New Jersey
$1.2M +$537K +16,350 +77%
BFM
46
Boothbay Fund Management
New York
$1.18M -$201K -6,113 -14%
Allianz Asset Management
47
Allianz Asset Management
Germany
$1.16M -$483K -14,688 -29%
BCM
48
Burrage Capital Management
Massachusetts
$1.12M +$1.15M +34,891 New
SSA
49
Schonfeld Strategic Advisors
New York
$1.07M +$828K +25,213 +311%
Ensign Peak Advisors
50
Ensign Peak Advisors
Utah
$1.02M +$241K +7,351 +30%
1
2
3 4 5

BDTX Hedge Fund Activity: Q4 2020 in Review

109 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Black Diamond Therapeutics (BDTX) for Q4 2020, worth a combined $915M — up 28% from $717M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new BDTX positions and 12 closed out — a net gain of 21 holders — while 43 added to existing stakes and 11 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $19.9M. The largest seller was Vivo Capital, exiting entirely with an estimated $4.4M sold.

  • 109 institutional investors held Black Diamond Therapeutics (BDTX) as of Q4 2020, up from 88 in Q3 2020.
  • Funds reported $915M of Black Diamond Therapeutics stock for Q4 2020, up 28% quarter-over-quarter.
  • 33 funds opened new Black Diamond Therapeutics positions in Q4 2020 and 12 closed out, a net change of +21 holders.
  • The largest Black Diamond Therapeutics buyer in Q4 2020 was Point72 Asset Management, an estimated $19.9M added.
  • The largest Black Diamond Therapeutics seller in Q4 2020 was Vivo Capital, an estimated $4.4M sold.

Based on aggregated 13F filings for Q4 2020.